Luca Braga

King's College London — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index3.7kcitations68works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Congenital heart defects research(11), Cardiac Fibrosis and Remodeling(8), MicroRNA in disease regulation(7), RNA Research and Splicing(7), Virus-based gene therapy research(7)

Publications68 total

<i>CLIPPER</i> Regulates LPIN1-Mediated Mitochondrial Biogenesis and Heart Regeneration
Circulation Research·2026· 1 cited
Molecular Profiling and High-Content Drug Screening of Metastatic Colorectal Cancer Organoids Reveal Evolutionary Mechanisms of Pan-KRAS Inhibitor Resistance
2026
Epigenetic Drugs Splitomicin, Suberohydroxamic Acid, CPTH6, BVT-948, and PBIT Moderate Fibro-Fatty Development in Arrhythmogenic Cardiomyopathy
Biomolecules·2025Open Access
Dual regulatory role of hsa-miR-122b-5p in chikungunya virus infection via interaction with CHIKV 3′-UTR and HDAC4 modulation
Journal of Virology·2025Open Access
Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies
British Journal of Cancer·2025· 1 citedOpen Access
Drug-Repurposing Screen Identifies Thiostrepton as a Novel Regulator of the Tumor Suppressor DAB2IP
Biomolecules·2025Open Access
Development and evaluation of an auto-tunable CircR-miRNAs sponges as innovative anti-miRNA therapy for Idiopatic Pulmonary fibrosis (IPF).
2025
Anti-miRNA therapeutics for uterine fibroids
Biomedicine & Pharmacotherapy·2025· 4 citedOpen Access
Functional screening identifies miRNAs with a novel function inhibiting vascular smooth muscle cell proliferation
Molecular Therapy·2024· 2 citedOpen Access
Regulation of human papillomavirus E6 oncoprotein function via a novel ubiquitin ligase FBXO4
mBio·2024· 3 citedOpen Access
Observational study on the use of subcutaneous recombinant IFN-γ as adjunctive personalized treatment for patients with life-threatening non-tuberculous mycobacteriosis
2024
LSC - 2024 - microRNA-Based Approaches Targeting Alveolar Epithelial Cells as Pro-Regenerative Treatment in Idiopathic Pulmonary Fibrosis
2024
Emerin mislocalization during chromatin bridge resolution can drive prostate cancer cell invasiveness in a collagen-rich microenvironment
Experimental & Molecular Medicine·2024· 4 citedOpen Access
Endothelial-to-mesenchymal transition enhances permissiveness to AAV vectors in cardiac endothelial cells
Molecular Therapy·2024· 2 citedOpen Access
Drug-repurposing screen identifies thiostrepton as a novel regulator of the tumor suppressor DAB2IP
2024
Discovery platforms for RNA therapeutics
British Journal of Pharmacology·2024· 6 citedOpen Access
Exploring the interactions between cardiomyocytes and endothelial cells to induce cardiac revascularization and regeneration
Cardiovascular Research·2024Open Access
Pauperization of Emerin from nuclear envelope during chromatin bridge resolution drives prostate cancer cell migration and invasiveness
2024Open Access
Functional screening identifies novel miRNAs inhibiting Vascular Smooth Muscle Cell proliferation
2024· 1 citedOpen Access
<i>Pseudomonas fuscovaginae</i> quorum sensing studies: 5% dominates cell-to-cell conversations
Microbiology Spectrum·2024· 4 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Mauro Giacca(30), Serena Zacchigna(18), Maria Concetta Volpe(13), Marco Confalonieri(11), Hashim Ali(10), Francesco Salton(9), Chiara Collesi(8), Nadja Ring(8), Lorena Zentilin(7), Rossana Bussani(7), Edoardo Schneider(7), Andrea Colliva(7), Barbara Ruaro(7), Paola Confalonieri(7), Serena Maiocchi(7), Simone Vodret(6), Ilaria Secco(4), Fabrizio Zanconati(4), Daniel H. Goldhill(3), Rebecca Penn(3)